Yiheng Capital Management
Yiheng Capital Management reported 25 stocks worth $235M in its 13F filing for Q2 2026, filed Aug 14, 2026. Its largest holdings are NOAH (28.6%), BILI (10.8%) and JD (6.4%). Compared with Q1 2026, the fund opened new positions in PSIX, BIOA and TOUR, added to BILI, JD and VRDN, trimmed HNGE, SVCO and EDU and sold out of CLBT and TOUR.
Holdings
| # | Stock | Value | Weight | Shares | Change | Shares, 8 qtrs | Held |
|---|---|---|---|---|---|---|---|
| 1 |  NOAH Noah Hldgs Ltd | $67.1M | 28.6% | 6.7M | No change | 8 of 8 | |
| 2 |  BILI Bilibili Inc | $25.4M | 10.8% | 1.5M | +750K (+101%) | 8 of 8 | |
| 3 |  JD Jd.com Inc | $15M | 6.4% | 591K | +3,000 (+1%) | 8 of 8 | |
| 4 |  HTHT H World Group Ltd | $13.5M | 5.8% | 323K | No change | 8 of 8 | |
| 5 |  HNGE Hinge Health Inc | $13M | 5.5% | 156K | −141K (−47%) | 2 of 8 | |
| 6 |  SVCO Silvaco Group Inc | $12.5M | 5.3% | 906K | −190K (−17%) | 6 of 8 | |
| 7 |  RERE Atrenew Inc | $12.2M | 5.2% | 3.2M | No change | 8 of 8 | |
| 8 |  BILL Bill Holdings Inc | $8.1M | 3.4% | 223K | No change | 2 of 8 | |
| 9 |  EDU NEW ORIENTAL ED & TECHNOLOGY | $7.5M | 3.2% | 1,636 | −375K (−100%) | 8 of 8 | |
| 10 |  VRDN Viridian Therapeutics Inc | $7.4M | 3.1% | 400K | +192K (+92%) | 8 of 8 |
Positions at Jun 30, 2026, as reported. Change is against the fund's Q1 2026 filing; weight is the share of the fund's reported stocks.
Sold out
held in Q1 2026, gone in Q2 2026
Options
valued at the underlying sharesReported value
last 8 quartersThe value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.
Filings for Q2 2026
straight from the SEC| Filed | Form | Quarter | |
|---|---|---|---|
| Aug 14, 2026 | 13F-HR | Q2 2026 | SEC filing ↗ |
Other superinvestors
All hedge fund holdings →Yiheng Capital Management 13F FAQ
What does Yiheng Capital Management own?
Yiheng Capital Management reported 25 stocks worth $235M in its 13F filing for Q2 2026, filed Aug 14, 2026. Its largest holdings are NOAH (28.6%), BILI (10.8%) and JD (6.4%). The table above lists every position in the filing (the top 10 without an account).
What did Yiheng Capital Management buy and sell in Q2 2026?
Compared with Q1 2026: 3 new positions, 5 added to, 4 trimmed and 2 sold out. New positions include PSIX, BIOA and TOUR. It sold all of CLBT and TOUR.
When will Yiheng Capital Management file its next 13F?
Holdings as of Sep 30, 2026 are due by Nov 16, 2026. The filing appears on this page within minutes of reaching the SEC.
How much is Yiheng Capital Management's portfolio worth?
The Q2 2026 filing reports $235M in US stocks ($291M including options). That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.